loadpatents
name:-0.019227027893066
name:-0.016272068023682
name:-0.0016798973083496
Nylof; Martin Patent Filings

Nylof; Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nylof; Martin.The latest application filed is for "compounds and their use as bace inhibitors".

Company Profile
1.15.18
  • Nylof; Martin - Sodertalje SE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds and their use as BACE inhibitors
Grant 10,231,967 - Csjernyik , et al.
2019-03-19
Compounds And Their Use As Bace Inhibitors
App 20180221367 - Csjernyik; Gabor ;   et al.
2018-08-09
Compounds and their use as BACE inhibitors
Grant 9,918,985 - Csjernyik , et al. March 20, 2
2018-03-20
Compounds And Their Use As Bace Inhibitors
App 20170319578 - Csjernyik; Gabor ;   et al.
2017-11-09
Compounds And Their Use As Bace Inhibitors
App 20160184303 - Csjernyik; Gabor ;   et al.
2016-06-30
Compounds and their use as BACE inhibitors
Grant 9,248,129 - Csjernyik , et al. February 2, 2
2016-02-02
Compounds And Their Use As Bace Inhibitors
App 20150133471 - Csjernyik; Gabor ;   et al.
2015-05-14
Compounds and their use as BACE inhibitors
Grant 8,865,911 - Csjernyik , et al. October 21, 2
2014-10-21
Compounds and Their Use as BACE Inhibitors
App 20130210837 - Csjernyik; Gabor ;   et al.
2013-08-15
Compounds and their use as BACE inhibitors
Grant 8,415,483 - Csjernyik , et al. April 9, 2
2013-04-09
New Compounds 806
App 20120238579 - Besidki; Yevgeni ;   et al.
2012-09-20
Compounds and their use as BACE Inhibitors
App 20120165347 - Csjernyik; Gabor ;   et al.
2012-06-28
Compounds
Grant 8,168,668 - Besidski , et al. May 1, 2
2012-05-01
N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
Grant 8,143,408 - Besidski , et al. March 27, 2
2012-03-27
New Compounds
App 20100286202 - Besidski; Yevgeni ;   et al.
2010-11-11
Novel N-(8-heteroaryltetrahydronaphtalene-2yl) Or N-(5-heteroarylchromane-3-yl) Carboxamide Derivatives For The Treatment Of Pain
App 20100137322 - Besidski; Yevgeni ;   et al.
2010-06-03
Benzimidazole derivatives
Grant 7,645,784 - Besidski , et al. January 12, 2
2010-01-12
Compounds
Grant 7,618,993 - Besidski , et al. November 17, 2
2009-11-17
New Compounds
App 20090149460 - Berg; Stefan ;   et al.
2009-06-11
Compounds
App 20080171770 - Besidski; Yevgeni ;   et al.
2008-07-17
3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3
Grant 7,399,780 - Berg , et al. July 15, 2
2008-07-15
Substituted chroman derivatives
Grant 7,384,943 - Berg , et al. June 10, 2
2008-06-10
New Heterocyclic Amides
App 20080015222 - Besidski; Yevgeni ;   et al.
2008-01-17
New benzimidazole derivatives
App 20060287377 - Besidski; Yevgeni ;   et al.
2006-12-21
Substituted chroman derivatives
App 20060223828 - Berg; Stefan ;   et al.
2006-10-05
Substituted chroman derivatives
Grant 7,056,921 - Berg , et al. June 6, 2
2006-06-06
Compounds
App 20050153987 - Berg, Stefan ;   et al.
2005-07-14
Substituted chroman derivatives
App 20040157857 - Berg, Stefan ;   et al.
2004-08-12
Substituted chroman derivatives
Grant 6,670,359 - Berg , et al. December 30, 2
2003-12-30
Substituted chroman derivatives
App 20030100556 - Berg, Stefan ;   et al.
2003-05-29
Substituted chroman derivatives
Grant 6,479,497 - Berg , et al. November 12, 2
2002-11-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed